DK143339C - Analogifremgangsmaade til fremstilling af 6-oxo-7,7-disubstitueret-1,2,7,8-tetrahydro-6h-indeno(5,4-b)furan-2-carboxylsyrer - Google Patents

Analogifremgangsmaade til fremstilling af 6-oxo-7,7-disubstitueret-1,2,7,8-tetrahydro-6h-indeno(5,4-b)furan-2-carboxylsyrer

Info

Publication number
DK143339C
DK143339C DK56076A DK56076A DK143339C DK 143339 C DK143339 C DK 143339C DK 56076 A DK56076 A DK 56076A DK 56076 A DK56076 A DK 56076A DK 143339 C DK143339 C DK 143339C
Authority
DK
Denmark
Prior art keywords
indeno
disubstituted
furan
tetrahydro
oxo
Prior art date
Application number
DK56076A
Other languages
Danish (da)
English (en)
Other versions
DK143339B (da
DK56076A (da
Inventor
Jr E J Cragoe
Jr O W Woltersdorf
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK56076A publication Critical patent/DK56076A/da
Publication of DK143339B publication Critical patent/DK143339B/da
Application granted granted Critical
Publication of DK143339C publication Critical patent/DK143339C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK56076A 1975-02-24 1976-02-11 Analogifremgangsmaade til fremstilling af 6-oxo-7,7-disubstitueret-1,2,7,8-tetrahydro-6h-indeno(5,4-b)furan-2-carboxylsyrer DK143339C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/552,402 US3984552A (en) 1975-02-24 1975-02-24 6-Oxo-7-substituted and 7,7-disubstituted-6H-indeno-[5,4-b]furan (and thiophene) carboxylic acids
US55240275 1975-02-24

Publications (3)

Publication Number Publication Date
DK56076A DK56076A (da) 1976-08-25
DK143339B DK143339B (da) 1981-08-10
DK143339C true DK143339C (da) 1981-12-07

Family

ID=24205173

Family Applications (1)

Application Number Title Priority Date Filing Date
DK56076A DK143339C (da) 1975-02-24 1976-02-11 Analogifremgangsmaade til fremstilling af 6-oxo-7,7-disubstitueret-1,2,7,8-tetrahydro-6h-indeno(5,4-b)furan-2-carboxylsyrer

Country Status (15)

Country Link
US (1) US3984552A (OSRAM)
JP (1) JPS6154794B2 (OSRAM)
AU (1) AU500514B2 (OSRAM)
BE (1) BE838828A (OSRAM)
CA (1) CA1072972A (OSRAM)
CH (1) CH617689A5 (OSRAM)
DE (1) DE2607305C2 (OSRAM)
DK (1) DK143339C (OSRAM)
ES (1) ES445380A1 (OSRAM)
FR (1) FR2301246A1 (OSRAM)
GB (1) GB1497382A (OSRAM)
HU (1) HU177120B (OSRAM)
NL (1) NL7601295A (OSRAM)
SE (1) SE425605B (OSRAM)
ZA (1) ZA761046B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394385A (en) * 1980-11-21 1983-07-19 Merck & Co., Inc. Treatment of gray matter edema
US6890363B1 (en) * 1999-05-24 2005-05-10 Showa Denko K.K. Solid electrolytic capacitor and method for producing the same
US6858614B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
EP2722042B1 (en) 2011-06-16 2019-05-29 Korea Research Institute of Chemical Technology Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
PT3882244T (pt) 2012-12-14 2025-04-04 Univ Leuven Kath Composto, sal farmaceuticamente aceitável ou isómero ótico do mesmo, método para a sua preparação e composição farmacêutica para prevenção ou tratamento de doenças virais que contenha o mesmo como ingrediente ativo
PE20151054A1 (es) 2012-12-17 2015-08-07 Parion Sciences Inc Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
CN115916763B (zh) 2020-04-20 2025-06-03 诺华股份有限公司 抗病毒素1,3-二氧代茚化合物
KR102894005B1 (ko) 2020-04-20 2025-12-03 노파르티스 아게 항바이러스 1,3-다이-옥소-인덴 화합물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931239A (en) * 1974-04-03 1976-01-06 Merck & Co., Inc. 6-Oxo-7-substituted-6H-indeno-[5,4-b]furan(and thiophene)-carboxylic acids

Also Published As

Publication number Publication date
FR2301246B1 (OSRAM) 1980-06-20
ZA761046B (en) 1977-03-30
ES445380A1 (es) 1977-10-01
DE2607305A1 (de) 1976-09-02
HU177120B (en) 1981-07-28
AU1117976A (en) 1977-08-25
DK143339B (da) 1981-08-10
JPS51110558A (OSRAM) 1976-09-30
SE7601422L (sv) 1976-08-25
SE425605B (sv) 1982-10-18
CH617689A5 (OSRAM) 1980-06-13
AU500514B2 (en) 1979-05-24
NL7601295A (nl) 1976-08-26
US3984552A (en) 1976-10-05
CA1072972A (en) 1980-03-04
GB1497382A (en) 1978-01-12
BE838828A (fr) 1976-08-23
DK56076A (da) 1976-08-25
DE2607305C2 (de) 1987-04-30
FR2301246A1 (fr) 1976-09-17
JPS6154794B2 (OSRAM) 1986-11-25

Similar Documents

Publication Publication Date Title
DK298176A (da) Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK143708C (da) Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16alfa-methyl-pregna-1,4-dien-3,20-dion-forbindelser
DK247076A (da) Fremgangsmade til fremstilling af sur protease
DK159787C (da) Fremgangsmaade til fremstilling af 3',4'-dideoxykanamycin b
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK153489C (da) Analogifremgangsmaade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater
DK139267B (da) Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivater
DK150484C (da) Analogifremgangsmaade til fremstilling af 4-amino-3-thiophencarboxylsyrederivater
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK143757C (da) Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener
DK138743B (da) Analogifremgangsmåde til fremstilling af 1-oxo-1H-pyrimido (1,2-a)quinolin-2-carboxylsyre-forbindelser.
DK147973C (da) Analogifremgangsmaade til fremstilling af 1,4-diphenyl-3-pyrazolyleddikesyrer
DK143137C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK143281C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK154888C (da) Analogifremgangsmaade til fremstilling af 6-substituerede-6-methoxypenicillansyrederivater
DK219776A (da) Fremgangsmade til fremstilling af 1,2-benzothiazin-oxadiazolforbindelse
DK137957B (da) Analogifremgangsmåde til fremstilling af 2-substituerede 5-fluorpyrimidin-4-oner.
DK143346C (da) Fremgangsmaade til fremstilling af 0,0-dialkylthionophosphorsyrechlorider
DK526476A (da) Fremgangsmade til fremstilling af apiro(cyklopropan-1,2i-indolin)-3i-oner
DK475376A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo/4,3,1,03,7/decan-forbindelser
DK29276A (da) Fremgangsmade til fremstilling af 8-bromothieno-triazolo-1,4-diazepiner
DK280376A (da) Fremgangsmade til fremstilling af 1-acyl-1,2,3,4-tetrahydro-6-quinoliner
DK150543C (da) Analogifremgangsmaade til fremstilling af 4-phenyl-3-oxo-1,2,4-oxadiazinderivater
DK146593C (da) Analogifremgangsmaade til fremstilling af fluorprostaglandiner

Legal Events

Date Code Title Description
PBP Patent lapsed